The Resorbable Magnesium Scaffold Magmaris in Acute Coronary Syndrome: An Appraisal of Evidence and User Group Guidance

被引：10

作者：

Bennett, Johan ^{[1
,2
]}

Ielasi, Alfonso ^{[3
]}

Torzewski, Jan ^{[4
]}

de Hemptinne, Quentin ^{[5
]}

Cerrato, Enrico ^{[6
,7
]}

Lanocha, Magdalena ^{[8
]}

Galli, Stefano ^{[9
]}

Sabate, Manel ^{[10
]}

机构：

[1] Univ Hosp Leuven, Dept Cardiovasc Med, Herestr 49, B-3000 Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[3] Ist Clin St Ambrogio, Seriate & Intervent Cardiol Unit, Cardiol Div ASST Bergamo Est, Milan, Italy

[4] Cardiovasc Ctr Oberallgau Kempten, Kempten, Germany

[5] Univ Libre Bruxelles, Dept Cardiol, CHU St Pierre, Brussels, Belgium

[6] San Luigi Gonzaga Univ Hosp Orbassano, Intervent Cardiol Unit, Turin, Italy

[7] Rivoli Infermi Hosp Rivoli, Turin, Italy

[8] St Adalberts Hosp, Poznan, Poland

[9] Univ Milan, Monzino Cardiol Ctr, Res & Teaching Hosp, Milan, Italy

[10] Hosp Clin Barcelona, Dept Cardiol, Barcelona, Spain

来源：

CARDIOVASCULAR REVASCULARIZATION MEDICINE | 2022年 / 39卷

关键词：

Magmaris; Acute coronary syndrome; Clinical outcomes; ELEVATION MYOCARDIAL-INFARCTION; BIORESORBABLE VASCULAR SCAFFOLD; ABSORBABLE METAL SCAFFOLD; CLINICAL-OUTCOMES; IDEAL SCENARIO; ELUTING STENTS; IMPLANTATION; PERFORMANCE; SAFETY;

D O I：

10.1016/j.carrev.2021.09.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bioresorbable scaffolds provide transient vessel support without the long-term limitations of permanent metallic drug-eluting stents. The sirolimus-eluting resorbable magnesium scaffold Magmaris is the only CE-marked metallic bioresorbable scaffold and provides short-term lumen support before being completely bioresorbed. To date, clinical trial results have demonstrated low adverse event rates in patients with simple coronary lesions. Seven European centers with large experience in Magmaris implantation, combined efforts in an informal collaboration to evaluate and appraise clinical data currently available regarding the performance of Magmaris in patients presenting with acute coronary syndromes, and to supply user-advice on patient selection and optimal implantation practice. (C) 2021 Elsevier Inc. All rights reserved.

引用

页码：106 / 113

页数：8

共 34 条

[1] 12-month clinical outcomes after Magmaris percutaneous coronary intervention in a real-world cohort of patients: Results from the CardioHULA registry [J].

Abellas-Sequeiros, Rosa A. ;

Ocaranza-Sanchez, Raymundo ;

Bayon-Lorenzo, Jeremias ;

Santas-Alvarez, Melisa ;

Gonzalez-Juanatey, Carlos .

REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (08) :421-425

[2] Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy [J].

Bennett, Johan ;

De Hemptinne, Quentin ;

McCutcheon, Keir .

EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (09) :757-769

[3] In-Vivo Vascular Healing Following Bifurcation Interventions with the Absorb Bioresorbable Vascular Scaffold [J].

Bennett, Johan ;

Verbeken, Eric ;

Vanhaverbeke, Maarten ;

McCutcheon, Keir ;

Adriaenssens, Tom ;

Driessch, Nina Vanden ;

Sinnaeve, Peter ;

Desmet, Water ;

Dubois, Christophe .

CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (01) :70-77

[4] Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial [J].

Byrne, Robert A. ;

Alfonso, Fernando ;

Schneider, Simon ;

Maeng, Michael ;

Wiebe, Jens ;

Kretov, Evgeny ;

Bradaric, Christian ;

Rai, Himanshu ;

Cuesta, Javier ;

Rivero, Fernando ;

Hoppmann, Petra ;

Schlichtenmaier, Jana ;

Christiansen, Evald H. ;

Cassese, Salvatore ;

Joner, Michael ;

Schunkert, Heribert ;

Laugwitz, Karl-Ludwig ;

Kastrati, Adnan .

EUROPEAN HEART JOURNAL, 2019, 40 (02) :167-176

[5] Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data [J].

Cassese, Salvatore ;

Katagiri, Yuki ;

Byrne, Robert A. ;

Brugaletta, Salvatore ;

Alfonso, Fernando ;

Raber, Lorenz ;

Maeng, Michael ;

Iniguez, Andres ;

Kretov, Evgeny ;

Onuma, Yoshinobu ;

Joner, Michael ;

Sabate, Manel ;

Laugwitz, Karl-Ludwig ;

Windecker, Stephan ;

Kastrati, Adnan ;

Serruys, Patrick W. .

EUROINTERVENTION, 2020, 15 (16) :1451-+

[6]

de Hemptinne Q, 2018, J INVASIVE CARDIOL, V30, P202

[7] Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016 [J].

Fajadet, Jean ;

Haude, Michael ;

Joner, Michael ;

Koolen, Jacques ;

Lee, Michael ;

Tolg, Ralph ;

Waksman, Ron .

EUROINTERVENTION, 2016, 12 (07) :828-833

[8] Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial [J].

Gomez-Lara, Josep ;

Ortega-Paz, Luis ;

Brugaletta, Salvatore ;

Cuesta, Javier ;

Romani, Sebastian ;

Serra, Antonio ;

Salinas, Pablo ;

Garcia del Blanco, Bruno ;

Goicolea, Javier ;

Hernandez-Antolin, Rosana ;

Antuna, Paula ;

Romaguera, Rafael ;

Regueiro, Ander ;

Rivero, Fernando ;

Cequier, Angel ;

Alfonso, Fernando ;

Gomez-Hospital, Joan-Antoni ;

Sabate, Manel .

EUROINTERVENTION, 2020, 16 (11) :E913-E921

[9] Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents Insights of the TROFI II Trial [J].

Gomez-Lara, Josep ;

Brugaletta, Salvatore ;

Ortega-Paz, Luis ;

Vandeloo, Bert ;

Moscarella, Elisabetta ;

Salas, Miguel ;

Romaguera, Rafael ;

Roura, Gerard ;

Ferreiro, Jose L. ;

Teruel, Luis ;

Gracida, Montserrat ;

Windecker, Stephan ;

Serruys, Patrick W. ;

Gomez-Hospital, Joan-Antoni ;

Sabate, Manel ;

Cequier, Angel .

JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) :1559-1571

[10] Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial [J].

Haude, Michael ;

Ince, Huseyin ;

Abizaid, Alexandre ;

Toelg, Ralph ;

Lemos, Pedro Alves ;

von Birgelen, Clemens ;

Christiansen, Evald Hoj ;

Wijns, William ;

Neumann, Franz-Josef ;

Kaiser, Christoph ;

Eeckhout, Eric ;

Lim, Soo Teik ;

Escaned, Javier ;

Onuma, Yoshinobu ;

Garcia-Garcia, Hector M. ;

Waksman, Ron .

EUROPEAN HEART JOURNAL, 2016, 37 (35) :2701-2709

← 1 2 3 4 →